Pearltec erhält weiteres Venture Capital – Berater: Trigon Medical AG

By on Juli 20, 2012

Pearltec AG, a private Swiss medical device company, announced today that the company has secured its financial future raising more than CHF 2 M in the Series-B financing. The financing was lead by a team of entrepreneurs around Pascal Stuerchler and supported by co-investors AKB (Aargauer Kantonalbank) and a group of Business-Angels. Existing investors ZKB, Berner Partners and Tugboat also participated in the financing. Acting as sole advisor in the transaction was Trigon Medical AG.

„Pearltec is a very interesting investment opportunity and I strongly believe in the new management team of the company,“ said Pascal Stuerchler, successful IT-Entrepreneur, who joins the Board of Directors of Pearltec. „We see a great potential for the innovative and very effective products of Pearltec who do not only improve hygiene and comfort for the patients undergoing a CT or MRI assessment, but can substantially improve the work-flow in a radiology unit and the quality of the images obtained. Beyond imaging, we see further potential in radio-therapy, patient-bedding during dental or surgical procedures and even applications beyond healthcare.“

In 2012 Pearltec has expanded its commercial activities in Europe and plans to enter the US market early 2013. The company is looking forward to achieving the required FDA regulatory filings within the next months and has already signed some declarations of intent with US domestic companies. Pearltec has also initiated a close cooperation with associations and schools for radiology assistants/radiographers.

„We are delighted to add successful business people and institutions to our investor base. I believe that their engagement validates the business opportunity for Pearltec and I am convinced that their involvement will support us to achieve our goals,“ said Dr. Thomas Müller, Founder and Chairman of Pearltec AG.

About Pearltec AG
Based in Zurich, Switzerland, privately held Pearltec, founded in 2008, is a spin-off from ETH Zurich. Pearltec develops and commercialized a novel generation of systems for patient positioning, bedding and immobilization during imaging procedures such as CT or MRI. Pearltec’s products enable a better image quality and provide more hygiene and comfort to the patient. At the same time the products of Pearltec improve the workflow and therefore time and cost efficiency in the radiology unit. Pearltec sells its CE-marked products directly and through a network of distributors in Europe.

For additional information contact:
Vincenzo Grande, CEO
+41 44 6337745
vincenzo.grande@pearltec.ch
www.pearltec.ch


Mehr Informationen zu dieser und vielen anderen Transaktionen erhalten Sie HIER


Über 25.000 recherchierte Transaktionen seit 2005 - Legen Sie sich Ihre eigene Datenbank zu!


Leave a Reply

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.